Bioceres Crop Solutions Corp. (BIOX) stock
BIOXNasdaqAgricultural ChemicalsFiscal year ends June 30
$0.22−0.01 (-4.60%)
Close on Nov 12, 2026Market cap $14.17MP/E –Yield –
Bioceres Crop Solutions total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Bioceres Crop Solutions's total debt was $107.24M at Jun 30, 2026. For fiscal 2026 it was $107.24M, down 32.1% from the year before. The highest annual figure on record is $178.85M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $107.24M | -32.1% |
| FY2025 | Jun 30, 2025 | $157.93M | -11.7% |
| FY2024 | Jun 30, 2024 | $178.85M | +6.3% |
| FY2023 | Jun 30, 2023 | $168.31M | +15.7% |
| FY2022 | Jun 30, 2022 | $145.48M | +16.6% |
| FY2021 | Jun 30, 2021 | $124.77M | +18.9% |
| FY2020 | Jun 30, 2020 | $104.95M | +1.3% |
| FY2019 | Jun 30, 2019 | $103.56M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $107.24M | -37.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $124.22M | -33.3% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $138.94M | -16.9% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $157.93M | -11.7% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $171.34M | +5.1% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $186.11M | +28.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $167.24M | +11.9% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $178.85M | +6.3% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $163.08M | -7.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $145.04M | -21.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $149.51M | +2.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $168.31M | +21.1% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $175.95M | +41.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $184.57M | +55.3% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $145.48M | +38.6% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $138.97M | +25.0% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $124.77M | +20.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $118.83M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $104.95M | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $111.17M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $103.56M | – |
See a number that looks wrong?